Body mass index and the risk of development of end-stage renal disease in a screened cohort

Kidney International

Volumn 65, Issue 5, 2004, Pages 1870-1876

  Iseki, Kunitoshi ^a   Ikemiya, Yoshiharu ^b   Kinjo, Kozen ^b   Inoue, Taku ^b   Iseki, Chiho ^b   Takishita, Shuichi ^b  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NONE

Author keywords

Body mass index; End stage renal disease; Screening

Indexed keywords

ADULT; BODY MASS; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; JAPAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

EID: 2342503209     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00582.x     Document Type: Conference Paper

References (36)

1. NAKAI S, SHINZATO T, SANAKA T, et al: The current state of chronic dialysis treatment in Japan (as of December 31, 2000). J Jpn Soc Dial Ther 35:1155-1184, 2002
2. US RENAL DATA SYSTEM: Excerpts from the USRDS 2001 Annual Data Report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 38(Suppl 3):S1-S248, 2001
3. SCHENA FP: Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy. Kidney Int 57(Suppl 74):S39-S45, 2000
4. KENCHAIAH S, EVANS JC, LEVY D, et al: Obesity and the risk of heart failure. N Engl J Med 347:305-313, 2002
5. CALLE EE, RODRIGUUEZ C, THURMOND KW, THUN MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638, 2003
6. MANSON JE, WILLETT WC, STAMPFER MJ, et al: Body weight and mortality among women. N Engl J Med 333:677-685, 1995
7. MUST A, SPADANO J, COAKLEY EH, FIELD AE: The disease burden associated with overweight and obesity. JAMA 282:1523-1529, 1999
8. ISEKI K, EKEMIYA Y, ISEKI C, TAKISHITA S: Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63:1468-1474, 2003
9. ISEKI K: The Okinawa Screening Program. J Am Soc Nephrol 14:S127-S130, 2003
10. RAMIREZ SP, MCCLELLAN W, PORT FK, HSU SIH: Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc Nephrol 13:1907-1917, 2002
11. TOZAWA M, ISEKI K, ISEKI C, et al: Influence of smoking and obesity on the development of proteinuria. Kidney Int 62:956-962, 2002
12. BRENNER BM, CHERTOW GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23:171-175, 1994
13. ISEKI K, IKEMIYA Y, FUKIYAMA K: Predictors of end-stage renal disease and body mass index in a screened cohort. Kidney Int 52(Suppl 63):S169-S170, 1997
14. ISEKI K, TOZAWA M, ISEKI C, et al: Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971-2000). Kidney Int 61:668-675, 2002
15. SPANGLER JG, KONEN JC: Hypertension, hyperlipidemia, and abdominal obesity and the development of microalbuminuria in patients with non-insulin-dependent diabetes mellitus. J Am Board Fam Pract 9:1-6, 1996
16. REID M, BENNETT F, WILKS R, FORRESTER T: Microalbuminuria, renal function and waist: Hip ratio in black hypertensive Jamaicans. J Hum Hypertens 12:221-227, 1998
17. METCALF P, BAKER J, SCOTT A, et al: Albuminuria in people at least 40 years old: Effect of obesity, hypertension, and hyperlipidemia. Clin Chem 38:1802-1808, 1992
18. PRAGA M, HERNANDEZ E, ANDRES A, et al: Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 70:35-41, 1995
19. TOZAWA M, ISEKI K, ISEKI C, et al: Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension 41:1341-1345, 2003
20. KUCZMARSKI RJ, FLEGAL KM, CAMPBELL SM, JOHNSON CL: Increasing prevalence of overweight among US adults. JAMA 272:205-211, 1994
21. ISEKI K, OSHIRO S, TOZAWA M, et al: Prevalence and correlates of diabetes mellitus in a screened cohort in Okinawa, Japan. Hypertens Res 25:185-190, 2002
22. KELLER G, ZIMNER G, MALL G, et al: Nephron number in patients with primary hypertension. N Engl J Med 348:101-108, 2003
23. LUFT FC: Food intake and the kidney: The right amounts at the right times. Am J Kidney Dis 37:629-631, 2000
24. USAMI T, KOYAMA K, TAKEUCHI O, et al: Regional variation in the incidence of end-stage renal failure in Japan. JAMA 284:2622-2624, 2000
25. MERLET-BENICHOU C, GILBERT T, VILAR J, et al: Nephron number: Variability is the rule. Causes and consequences. Lab Invest 79:515-527, 1999
26. HOPPER J, JR, TREW PA, BIAVA CG: Membranous nephropathy: Its relative benignity in women. Nephron 29:18-24, 1981
27. DONADIO JV, JR, TORRES VE, VELOSA JA, et al: Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 33:708-715, 1988
28. GRETZ N, ZEIER M, GERBERTH S, et al: Is gender a determinant for evolution of renal disease? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis 14:178-183, 1989
29. SAKEMI T, TOYOSHIMA H, MORITO F: Testosterone eliminates the attenuating effect of castration on the progressive glomerular injury in hypercholesterolemic male Imai rats. Nephron 67:469-476, 1994
30. HORNER D, FLISER D, KLIMM HP, RITZ E: Albuminuria in normotensive and hypertensive individuals attending offices of general practitioners. J Hypertens 14:655-660, 1996
31. STEGMAYR B, LITHNER F: Tobacco and end stage diabetic nephropathy. BMJ 295:581-582, 1987
32. OLIVARIUS NDF, ANDERSEN AH, KEIDING N, MOGENSEN CE: Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients Cross-sectional data from the population-based study "Diabetes Care in General Practice," Denmark. Diabetologia 36:1007-1016, 1993
33. ORTH SR, STOCKMANN A, CONRADT C, et al: Smoking as a risk factor for end-stage renal disease in men with primary renal disease. Kidney Int 54:926-931, 1998
34. KOPPLE JD, GREENE T, CHUMLEA C, et al: Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD study. Kidney Int 57:1688-1703, 2000
35. NATIONAL KIDNEY FOUNDATION: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 39(Suppl 1):S1-S266, 2002
36. ISEKI K, IKEMIYA Y, FUKIYAMA K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 51:850-854, 1997